Vince Anzalone | VP, IR |
Christopher Anzalone | President and CEO |
Javier San Martin | Chief Medical Officer |
Ken Myszkowski | CFO |
James Hamilton | SVP, Discovery and Translational Medicine |
Tracie Oliver | Chief Commercial Officer |
Patrick O'Brien | Chief Operating Officer & General Counsel |
Luca Issi | RBC |
Ted Tenthoff | Piper Sandler |
Ellie Merle | UBS |
Joel Beatty | Baird |
Madhu Kumar | Goldman Sachs |
Patrick Trucchio | HC Wainwright |
Keay Nakae | Chardan |
Mani Foroohar | SVB Securities |
Mayank Mamtani | B. Riley FBR |
Prakhar Agarwal | Cantor |
Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions. I will now hand the conference over to Vince Anzalone, Vice President of Finance and Investor Relations for Arrowhead. Please go ahead, Vince.